Lineage, Inc. Common Stock (LINE)vsReal Brokerage Inc (REAX)
LINE
Lineage, Inc. Common Stock
$37.75
+0.96%
REAL ESTATE · Cap: $9.50B
REAX
Real Brokerage Inc
$20.28
+9.44%
REAL ESTATE · Cap: $392.95M
Smart Verdict
WallStSmart Research — data-driven comparison
Lineage, Inc. Common Stock generates 140% more annual revenue ($5.37B vs $2.24B). REAX leads profitability with a -0.7% profit margin vs -3.1%. LINE earns a higher WallStSmart Score of 35/100 (F).
LINE
Avoid35
out of 100
Grade: F
REAX
Avoid33
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Safe zone — low bankruptcy risk
Revenue surging 29.6% year-over-year
Areas to Watch
0.8% revenue growth
0.0% earnings growth
Operating margin of 3.7%
Elevated debt levels
0.0% earnings growth
Smaller company, higher risk/reward
Operating margin of 0.7%
Trading at 56.3x book value
Comparative Analysis Report
WallStSmart ResearchBull Case : LINE
The strongest argument for LINE centers on Price/Book.
Bull Case : REAX
The strongest argument for REAX centers on Altman Z-Score, Revenue Growth. Revenue growth of 29.6% demonstrates continued momentum.
Bear Case : LINE
The primary concerns for LINE are Revenue Growth, EPS Growth, Operating Margin.
Bear Case : REAX
The primary concerns for REAX are EPS Growth, Market Cap, Operating Margin.
Key Dynamics to Monitor
LINE profiles as a turnaround stock while REAX is a growth play — different risk/reward profiles.
LINE carries more volatility with a beta of 0.88 — expect wider price swings.
REAX is growing revenue faster at 29.6% — sustainability is the question.
LINE generates stronger free cash flow (186M), providing more financial flexibility.
Bottom Line
LINE scores higher overall (35/100 vs 33/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Lineage, Inc. Common Stock
REAL ESTATE · REIT - INDUSTRIAL · USA
Lineage, Inc. (Ticker: LINE) is a pioneering biotechnology firm dedicated to regenerative medicine, focusing on next-generation cell therapies targeting ocular diseases, spinal cord injuries, and various cancers. With its proprietary technologies and robust strategic collaborations, Lineage is at the forefront of developing transformative treatment options that aim to improve patient outcomes significantly. The company's commitment to enhancing its diverse product pipeline and expediting clinical trials makes it an attractive investment opportunity for institutional investors seeking exposure in the rapidly evolving healthcare landscape.
Visit Website →Real Brokerage Inc
REAL ESTATE · REAL ESTATE SERVICES · USA
Real Brokerage Inc. is a technology-driven residential real estate brokerage company. The company is headquartered in Toronto, Canada.
Visit Website →Compare with Other REIT - INDUSTRIAL Stocks
Want to dig deeper into these stocks?